Melanoma Clinical Trials

Showing 401-420 of 1,477 trials

Survival Monitoring in Russian Cancer Registries

NCT06043947

This study aims to establish a holistic framework for continuous cancer survival surveillance in Russian regions with high-quality population-based cancer registry data. The data from the population-based cancer registries of the Northwestern regions of Russia will be used to assess net and cause-specific survival trends.

MelanomaBreast CancerOncology+5 more

N.N. Petrov National Medical Research Center of Oncology100,000 participantsStarted Aug 2023

Saint Petersburg, Russia

COMPLETEDPhase 3

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

NCT03551626

The main purpose of this study was to evaluate the impact on pyrexia-related outcomes of an adapted pyrexia adverse event (AE)-management algorithm, as well as safety, efficacy and health-related outcomes.

Malignant Melanoma

Novartis Pharmaceuticals552 participantsStarted Aug 2018

Rosario, Sante Fe, Argentina • Buenos Aires, Argentina • Córdoba, Argentina +97 more locations

Survival Monitoring in Russian Cancer Registries

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Related Searches

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma

Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in Healthy Adults

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Head and Neck Melanoma; Access to Staging and Surgical Treatment

Needs and Preferences of Patients With Head-neck Cutaneous SCC

A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

Defining the Role of Optical Super-high Magnification Dermoscopy in the Diagnosis of Skin Tumors

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor

Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia